+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07659782

Phase 2 Open-Label Trial of Oral VS-7375 for Advanced KRAS G12D-Mutated Non-Small Cell Lung Cancer Previously Treated

Led by Verastem, Inc. · Updated on 2026-11-04

105

Participants Needed

24

Research Sites

78 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of VS-7375, given alone and combined with cetuximab, in patients with metastatic non-small cell lung cancer NSCLC that have a specific KRAS G12D mutation. This phase 2 open-label study focuses on patients who have already received prior treatments and whose cancer has progressed. The goal is to better understand how this oral KRAS G12D inhibitor works in this advanced lung cancer setting. Participants will receive VS-7375 orally in one of several dosing regimens depending on their prior treatments and disease characteristics, including groups for second or third line 2L3L therapy and those with brain metastases receiving second to fourth line 2L-4L therapy. The study uses a randomized crossover design and will assess responses to treatment over time. Different doses may be provided, and participants may be monitored for disease progression and side effects during the treatment period. Throughout the trial, participants will have regular evaluations including imaging scans to measure tumor size according to RECIST criteria, safety assessments, blood tests for pharmacokinetics and pharmacodynamics, and quality of life questionnaires. The main outcomes include confirmed tumor response rates and safety over six months, with additional measures tracked up to 2.5 years. The study will also observe time to next therapy and health-related quality of life changes, with monitoring continuing through the planned study period until 2028.

CONDITIONS

Brief Title

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

Research Team

V

Verastem Call Center

T

Ting Wu, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here